Abstract
Breast cancer is one of the most common malignancy which seriously harmful to the women′s health around the world. The application of PET/CT has remarkably improved the management of breast cancer. PET/CT offers advantages in evaluating breast cancer response to therapy and identifying patients who will not respond optimally to preoperative chemotherapy. In recent years , expression of spe-cific molecular markers in breast cancer, such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status, has direct influence on the prognosis and therapeutic regimen. Key words: Positron-emission tomography; Tomography,X-ray computed; Breast neoplasms; Neoadjuvant therapy; Prognosis evaluation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
